Journalist Hunt

Resources ▾

Journalist DatabaseFor JournalistsPricing
LoginSign up

Hannah Baker - Journalist Profile | Connect with top journalists

View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.

Get connected with journalists today
Medical Writer, reparerx.com

Hannah Baker

Verified

Medical Writer, reparerx.com

Austin

Beats

Primary beats

Healthu.s. regional

Secondary beats

Wine and spiritsWellnessFiction WritingHuman RightsDrinksFood and drinksSchoolsMedical ResearchConflictsSexPolicyWomen's LifestyleHolistic LivingMedia advising and social media promotionBig DataIVFPerforming ArtsWomen'S Interest

Biography

Final Covers

Women’s Health , Healthcare , Social And Health Inequality

Doesn’t Cover

Journalist Type

online / digital journalists

Seniority Positions

Medical Writer

Industries

Research

Medium Formats

reparerx.com

Content

Total articles 209

  • Available on paid plans

    TATSU-YA TAQUERO TAKEOVER at Suerte

    By Caitlin Cano, Sarah Connell, Hannah Baker Verified

    Aug. 02, 2022

  • Available on paid plans

    Late Night Glow Show w/ Joey Z at The Ballroom at Spiderhouse

    By Caitlin Cano, Hannah Baker Verified

    Jul. 26, 2022

  • Available on paid plans

    TATSU-YA TAQUERO TAKEOVER at Suerte

    By Caitlin Cano, Sarah Connell, Hannah Baker Verified

    Aug. 02, 2022

As seen in

Do512

Company Info

reparerx.com

Repare Therapeutics is a clinical-stage precision oncology company based in Quebec, Canada, founded in 2016. The company focuses on discovering and developing novel therapeutics through a proprietary synthetic lethality approach, targeting genomic instability and DNA damage repair. Utilizing its CRISPR-enabled SNIPRx® platform, Repare Therapeutics systematically identifies and validates targets for cancer therapies. The company has a diverse product pipeline aimed at addressing cancers with significant unmet medical needs and is actively engaged in clinical trials for these candidates. Repare Therapeutics is also involved in strategic partnerships, including the out-licensing of its discovery platforms to DCx Biotherapeutics. Listed on the Nasdaq under the ticker symbol RPTX, Repare Therapeutics operates with a team of 51 to 200 employees and has additional operations in Switzerland. The company is committed to advancing cancer treatment through innovative research and development.

, ,

'+1 857-412-7018

Founded: 2016


Journalist Hunt

Email us

contact@journalisthunt.com
Terms and ConditionsRefund PolicyPrivacy Policy

Copywright © 2025, Journalist Hunt. All right reserved